EKSO

#4430
Ekso Bionics Holdings, Inc. Common Stock
11.3550 USD
-0.13%
Secteur: Soins de Santé
Base: USD
Devise de Profit: USD
Range quotidien
10.8500
11.5000
Range Annuel
7.8900
13.5000
Changement quotidien
-0.13%
Changement Mensuel
+13.44%
Evolution sur 6 mois
-9.31%
Changement Annuel
-9.31%
Clôture Précédente
11.3700
Ouvrir
11.5000
Plus Bas
10.8500
High
11.5000
Volume
5
Afficher le graphique complet

Financials

Aperçu Relevé Statistiques
Trimestriel Annuel
Compte de résultat Bilan Flux de trésorerie
Valeur 202020212022202320242025 TTM

Ekso Bionics Holdings Inc

Ekso Bionics Holdings Inc. is a company that develops and manufactures powered exoskeleton bionic devices that can be strapped on as wearable robots to enhance the strength, mobility, and endurance of industrial workers and people experiencing paralysis and mobility issues after a brain injury, stroke, multiple sclerosis or spinal cord injury. They enable individuals with any amount of lower extremity weakness, including those who are paralyzed, to stand up and walk. Ekso Bionics currently focuses in the health and industrial sectors. The company's first commercially available health product was called EksoGT. Ekso Bionics is the original developer of HULC, now under military development by Lockheed Martin, and the current developers of EksoNR, which allows patients who are relearning to walk the ability to stand and take steps. In December 2022, Ekso Bionics acquired the Human Motion & Control business unit from Parker Hannifin which includes the Indego product line. This acquisition allowed Ekso Bionics to begin selling exoskeletons to those who have an SCI and want a personal exoskeleton to walk at home and in their community.

Nouvelles